Role of alpelisib in the treatment of pik3ca-mutated breast cancer: Patient selection and clinical perspectives

DWANG-YING CHANGWEI-LI MAYEN-SHEN LU2021-05-052021-05-0520211176-6336https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102877026&doi=10.2147%2fTCRM.S251668&partnerID=40&md5=05b3f1fb733ae988cb456b8aee8a4770https://scholars.lib.ntu.edu.tw/handle/123456789/559430[SDGs]SDG3Role of alpelisib in the treatment of pik3ca-mutated breast cancer: Patient selection and clinical perspectivesjournal article10.2147/TCRM.S2516682-s2.0-85102877026